Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
D000818:Animals; D001377:Azaserine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D002855:Chromatography, Thin Layer; D004357:Drug Synergism; D005260:Female; D006150:Guanine Nucleotides / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D006207:Half-Life; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D009705:Nucleosides / Q000627:therapeutic use; D009711:Nucleotides / Q000378:metabolism; D010529:Peritoneal Cavity; D012263:Ribonucleosides / Q000494:pharmacology*; D012265:Ribonucleotides / Q000378:metabolism; D012510:Sarcoma 180 / Q000188:drug therapy / Q000378:metabolism*; D013460:Sulfur Isotopes; D013866:Thioguanine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D014500:Uracil Nucleotides / Q000378:metabolism
D006150:Guanine Nucleotides; D009705:Nucleosides; D009711:Nucleotides; D012263:Ribonucleosides; D012265:Ribonucleotides; D013460:Sulfur Isotopes; D014500:Uracil Nucleotides; D006160:Guanosine Triphosphate; D001377:Azaserine; D015122:Mercaptopurine; D013866:Thioguanine